An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B
NCT ID: NCT01730508
Last Updated: 2017-07-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
978 participants
OBSERVATIONAL
2012-11-20
2017-06-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive Chronic Hepatitis B in Vietnam
NCT01886300
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive or HBeAg-Negative Chronic Hepatitis B
NCT01734018
Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B
NCT01760122
A Study of Peginterferon Alfa-2a [PEGASYS] in Patients With Chronic Hepatitis B Who Are HBeAg Positive
NCT01086085
A Study of Peginterferon Alfa-2a (Pegasys) in Participants With Hepatitis B E-Antigen (HBeAg)-Positive Chronic Hepatitis B Virus (HBV)
NCT02604823
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chronic Hepatitis B Participants
Hepatitis B e antigen (HBeAg) chronic hepatitis B (CHB) participants who received treatment with pegylated interferon alfa (peginterferon alfa) according to China labeling and China standard of care and were followed up to 1 year after treatment cessation.
Pegylated Interferon Alfa (Peginterferon Alfa)
Peginterferon alfa dosing and treatment duration are at the discretion of the investigator in accordance with China clinical practice and local labeling.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pegylated Interferon Alfa (Peginterferon Alfa)
Peginterferon alfa dosing and treatment duration are at the discretion of the investigator in accordance with China clinical practice and local labeling.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Treatment with Pegasys according to label and standard clinical practice
* HBeAg negative serologically proven chronic hepatitis B with or without cirrhosis
* Serum alanine aminotransferase (ALT) \> upper limit of normal (ULN) but \</= 10 x ULN
* Hepatitis B Virus (HBV) DNA \>/= 2000 IU/mL
Exclusion Criteria
* Co-infection with hepatitis A, hepatitis C or HIV
* Pregnant or lactating women
* Participants should not receive concomitant therapy with telbivudine
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hoffmann-La Roche
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Trials
Role: STUDY_DIRECTOR
Hoffmann-La Roche
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Fifth Hospital of Shijiazhuang
Baoding, , China
Beijing Ditan Hospital
Beijing, , China
Beijing 302 Hospital; No. 2 Infectious Disease Section
Beijing, , China
Beijing Friendship Hospital
Beijing, , China
Beijing You An Hospital; Digestive Dept
Beijing, , China
Peking University Third Hospital
Beijing, , China
Beijing Union Hospital
Beijing, , China
the First Hospital of Jilin University
Changchun, , China
Jilin Hepatobiliary Hospital
Changchun, , China
Peoples Hospital of Hunan Province
Changsha, , China
The Third Xiangya Hospital Of Central South University
Changsha, , China
Changzhou 3rd People's Hospital
Changzhou, , China
West China Hospital, Sichuan University
Chengdu, , China
The Second Affiliated Hospital, Chongqing Medical University
Chongqing, , China
The First Affiliated Hospital, Chongqing Medical University
Chongqing, , China
Southwest Hospital , Third Military Medical University
Chongqing, , China
6th Hospital of Dalian City
Dalian, , China
The First People's Hospital of Foshan
Foshan, , China
The First People's Hospital of Shunde
Foushan, , China
Fuzhou Infectious Diseases Hospital
Fuzhou, , China
The Eighth People's Hospital of Guangzhou
Guangzhou, , China
Guangdong General Hospital
Guangzhou, , China
The First Affiliated Hospital, Sun Yat-sen University
Guangzhou, , China
Guangzhou First Municipal People's Hospital
Guangzhou, , China
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Guangzhou, , China
Nanfang Hospital, Southern Medical University
Guangzhou, , China
The First Affiliated Hospital of Jinan University
Guangzhou, , China
Guangdong Provincial Traditional Chinese Medicine Hospital
Guangzhou, , China
Hainan provincial people's hospital
Haikou, , China
The First Affiliated Hospital of College of Medicine, Zhejiang University(First Hospital of Zhejiang
Hangzhou, , China
The Affiliated Hospital of Hangzhou Normal University
Hangzhou, , China
211 Military Hospital of China
Harbin, , China
The 4th Affiliated Hospital of Harbin Medical University
Harbin, , China
The First Affiliated Hospital of Anhui Medical University
Hefei, , China
Huai'an No 4 People's Hospital
Huai'an, , China
Jiangmen Wuyi Traditional Chinese Medicine Hospital
Jiangmen, , China
Jiangyin People's Hospital
Jiangyin, , China
Jinan Infectious Diseases Hospital
Jinan, , China
Third people's Hospital of Kunming City
Kunming, , China
The Second Gansu Province General Hospital
Lanzhou, , China
The First People's Hospital of Lian Yun Gang
Lianyungang, , China
Liuzhou Hospital of Traditional Chinese Medicine
Liuzhou, , China
Affiliated Hospital of Luzhou medical college
Luzhou, , China
The Ninth Hospital of Nanchang
Nanchang, , China
Nanjing No.2 Hospital; Liver Disease Department
Nanjing, , China
Jiangsu Province Hospital
Nanjing, , China
The 81st Hospital of P.L.A.
Nanjing, , China
Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine
Nanning, , China
The First Affiliate Hospital of Guangxi Medical University
Nanning, , China
Ningbo No.2 Hospital
Ningbo, , China
Ordos No.2 Hospital
Ordos, , China
QingDao Infection Diseases Hospital
Qingdao, , China
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, , China
Shanghai Public Health Clinical Center
Shanghai, , China
No.3 people's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, , China
Longhua Hospital, Shanghai University of Traditional Chinese Medicine
Shanghai, , China
Shanghai Huangpu District Central Hospital
Shanghai, , China
The First Affiliated Hospital, Shantou University
Shantou, , China
Shengjing Hospital of China Medical University
Shenyang, , China
Shenyang Sixth People's Hospital （Shenyang Infectious Disease Hospital）
Shenyang, , China
Shenzhen Donghu Hospital
Shenzhen, , China
The First Hospital of Hebei Medical University
Shijiazhuang, , China
Bethune International Peace Hospital of PLA
Shijiazhuang, , China
Suining Central Hospital
Suining, , China
The Fifth People's Hospital Suzhou; Infectious Disease
Suzhou, , China
The Third Hospital of Taiyuan (Taiyuan Infectious Diseases Hospital)
Taiyuan, , China
Jiangsu Taizhou People's Hospital
Taizhou, , China
Tianjin Infectious Disease Hospital
Tianjin, , China
Dagang Oil Field General Hospital
Tianjin, , China
Xinjiang Uygur Autonomous Region Hospital of Chinese Traditional Medicine
Ürümqi, , China
The First Teaching Hospital of Xinjiang Medical University
Ürümqi, , China
The First Affiliated Hospital of Wenzhou Medical College
Wenzhou, , China
Wenzhou Hospital of Traditional Chinese Medicine
Wenzhou, , China
Ruian People's Hospital
Wenzhou, , China
Tongji Hosp, Tongji Med. Col, Huazhong Univ. of Sci. & Tech
Wuhan, , China
Wuxi No.5 People's Hospital
Wuxi, , China
The Second Affiliated Hospital of The Fourth Military Medical University (Tangdu Hospital)
Xi'an, , China
Xiamen Hospital of T.C.M
Xiamen, , China
Xingtai People's Hospital
Xingtai, , China
The Affiliated Hospital of Xuzhou Medical College
Xuzhou, , China
Yancheng City No.1 People's Hospital
Yancheng, , China
Yangzhou Third People's Hospital
Yangzhou, , China
Central People's Hospital of Yichang
Yichang, , China
Chinese medicine hospital of Zhaoqing City
Zhaoqing, , China
Henan Provincial People's Hospital
Zhengzhou, , China
Zhenjiang Third People's Hospital
Zhenjiang, , China
Zhoushan Hospital
Zhoushan, , China
Zhuhai People's Hospital
Zhuhai, , China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Chen X, Mao Q, Xie Y, Dou X, Xie Q, Sheng J, Gao Z, Zhou X, Liu Y, Zheng H, Zhang S, Li S, Zhu F, Xu Y, Zhang M, Hu Y, Chen X, Huang Y, Ren H, Jia J. A Potential Functional Cure in Chinese HBeAg-negative Chronic Hepatitis B Patients Treated with Peg-interferon Alpha-2a. J Clin Transl Hepatol. 2019 Sep 28;7(3):249-257. doi: 10.14218/JCTH.2019.00016. Epub 2019 Aug 20.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ML28516
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.